Apparo Inc. has announced a Series A investment of $3.5 million co-led by Endeavor8 and Finistere Ventures, and joined by Blue Horizon.
Apparo Inc. (Eden Prairie, MN) has announced a Series A investment of $3.5 million co-led by Endeavor8 and Finistere Ventures, and joined by Blue Horizon, to support its development of sunflower protein ingredients incorporating Apparo’s Total Crop Utilization system. The system applies Apparo’s patent-pending technology to extract sunflower protein ingredients in order to meet the rising demands of the rapidly growing plant-based protein food market.
“At least 200,000 tons of plant protein ingredients are needed to reach the 2026 market demand, which is a huge opportunity for new sources of protein ingredients, particularly highly functional native proteins such as our Solistein sunflower protein isolate,” said Ian Mackay, CEO of Apparo, in a press release. “With two successful co-manufacturing trials for our Solistein ingredients, our experienced team is now poised for a rapid ramp up of the commercialization of our products.”
Apparo’s technology utilizes existing crop byproducts as a feedstock to create its Solistein protein ingredients. According to the company, it also allows Apparo to narrow the protein gap without additional impact to the environment.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.